AIM ImmunoTech (AIM) EBIT Growth (3y) (2013 - 2026)
AIM ImmunoTech (AIM) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 6.70% |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 8.36% |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 69.02% |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 24.14% |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 44.54% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 44.34% |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -28.30% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 81.27% |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | -18.82% |
| 10 | AIM ImmunoTech | 4.48 Mn | -5.48 Mn | 21,000.00 | 13.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.68% |
| Mar 31, 2026 | 19.67% |
| Dec 31, 2025 | 19.01% |
| Sep 30, 2025 | 27.87% |
| Jun 30, 2025 | 17.40% |
| Mar 31, 2025 | -4.71% |
| Dec 31, 2024 | 7.70% |
| Sep 30, 2024 | -4.54% |
| Jun 30, 2024 | 0.22% |
| Mar 31, 2024 | -15.26% |
| Dec 31, 2023 | -39.58% |
| Sep 30, 2023 | -34.47% |
| Jun 30, 2023 | -17.81% |
| Mar 31, 2023 | -8.91% |
| Dec 31, 2022 | -21.63% |
| Sep 30, 2022 | -26.72% |
| Jun 30, 2022 | -13.35% |
| Mar 31, 2022 | -2.51% |
| Dec 31, 2021 | -40.91% |
| Sep 30, 2021 | -8.95% |